clearn.png
Thursday April 15th, 2021 10:02PM

AstraZeneca COVID-19 vaccine study paused after one illness

By The Associated Press

Late-stage studies of AstraZeneca’s COVID-19 vaccine candidate are on temporary hold while the company investigates whether a recipient’s “potentially unexplained” illness is a side effect of the shot.

In a statement issued Tuesday evening, the company said its “standard review process triggered a pause to vaccination to allow review of safety data.”

AstraZeneca didn't reveal any information about the possible side effect except to call it “a potentially unexplained illness.” The health news site STAT first reported the pause in testing, saying the possible side effect occurred in the United Kingdom.

An AstraZeneca spokesperson confirmed the pause in vaccinations covers studies in the U.S. and other countries. Late last month, AstraZeneca began recruiting 30,000 people in the U.S. for its largest study of the vaccine. It also is testing the vaccine, developed by Oxford University, in thousands of people in Britain, and in smaller studies in Brazil and South Africa.

Two other vaccines are in huge, final-stage tests in the United States, one made by Moderna Inc. and the other by Pfizer and Germany's BioNTech. Those two vaccines work differently than AstraZeneca's, and the studies already have recruited about two-thirds of the needed volunteers.

Temporary holds of large medical studies aren't unusual, and investigating any serious or unexpected reaction is a mandatory part of safety testing. AstraZeneca pointed out that it's possible the problem could be a coincidence; illnesses of all sorts could arise in studies of thousands of people.

“We are working to expedite the review of the single event to minimize any potential impact on the trial timeline,” the company statement said.

It’s likely the unexplained illness was serious enough to require hospitalization and not a mild side effect such as fever or muscle pain, said Deborah Fuller, a University of Washington researcher who is working on a different COVID-19 vaccine that has not yet started human testing.

“This is not something to be alarmed about,” Fuller said. Instead, it’s reassuring that the company is pausing the study to figure out what’s happening and carefully monitoring the health of study participants.

Dr. Ashish Jha of Brown University said via Twitter that the significance of the interruption was unclear but that he was “still optimistic” that an effective vaccine will be found in the coming months.

“But optimism isn’t evidence,” he wrote. “Let’s let science drive this process.”

Angela Rasmussen, a virologist at Columbia University in New York, tweeted that the illness may be unrelated to the vaccine, "but the important part is that this is why we do trials before rolling out a vaccine to the general public.”

During the third and final stage of testing, researchers look for any signs of possible side effects that may have gone undetected in earlier patient research. Because of their large size, the studies are considered the most important study phase for picking up less common side effects and establishing safety.

The trials also assess effectiveness by tracking who gets sick and who doesn’t between patients getting the vaccine and those receiving a dummy shot.

The development came the same day that AstraZeneca and eight other drugmakers issued an unusual pledge, vowing to uphold the highest ethical and scientific standards in developing their vaccines.

The announcement follows worries that President Donald Trump will pressure the U.S. Food and Drug Administration to approve a vaccine before it’s proven to be safe and effective.

The U.S. has invested billions of dollars in efforts to quickly develop multiple vaccines against COVID-19. But public fears that a vaccine is unsafe or ineffective could be disastrous, derailing the effort to vaccinate millions of Americans.

Representatives for the FDA did not immediately respond to requests for comment Tuesday evening.

AstraZeneca’s U.S.-traded shares fell more than 6% in after-hours trading following reports of the trial being paused.

___

Associated Press writers Matthew Perrone and Carla K. Johnson contributed to this report.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

  • Associated Categories: Associated Press (AP), AP National News, AP Online National News, Top General short headlines, AP Health, AP Business, AP Business - Corporate News, AP Business - Industries, AP Business - Health Care
© Copyright 2021 AccessWDUN.com
All rights reserved. This material may not be published, broadcast, rewritten, or redistributed without permission.
Trump, Biden charge into volatile final stretch of campaign
For such a volatile year, the White House race between President Donald Trump and Democratic challenger Joe Biden has been remarkably consistent
6:49PM ( 9 minutes ago )
Computer glitches disrupt classes as schools return online
The millions of American youngsters returning to online classes Tuesday are facing technical glitches and other headaches that have plagued remote learning since the onset of the COVID-19 pandemic
6:38PM ( 19 minutes ago )
Colts' new kicker constructing new chapter as opener nears
Rodrigo Blankenship has some big shoes to fill for the Indianapolis Colts on Sunday at Jacksonville
6:25PM ( 32 minutes ago )
Associated Press (AP)
The Latest: Britain to ban social gatherings of more than 6
Social gatherings of more than six people will be banned in England from Monday, as the government tries to curb a significant rise in coronavirus cases
6:10PM ( 48 minutes ago )
The Latest: At least 1,000 ECU students have tested positive
At least 1,000 East Carolina University students have tested positive for the coronavirus since fall classes began on Aug. 10
5:40PM ( 1 hour ago )
The Latest: Las Vegas children contract inflammatory disease
Health officials said Tuesday that eight Las Vegas-area children under age 14 who tested positive for COVID-19 since March were also diagnosed with a rare inflammatory condition linked with the coronavirus
4:30PM ( 2 hours ago )
AP Health
7 killings investigated at illegal pot grow in California
Detectives are investigating what prompted the Labor Day killings of seven people at an illegal marijuana growing operation in a rural Southern California community known for horse ranches and plant nurseries along dirt roads
6:04PM ( 53 minutes ago )
Firefighters injured, airlifted in central California blaze
The U.S. Forest Service says 14 firefighters and bulldozer operators were injured Tuesday while battling a blaze in central California
5:58PM ( 59 minutes ago )
Tech’s sudden sell-off continues; Nasdaq sinks 10% in 3 days
Big technology stocks tumbled again on Tuesday, continuing the Icarus-like flight path for companies that just a week ago were the high-flyers carrying Wall Street to record heights
5:36PM ( 1 hour ago )
AP Business
Technology stocks keep stumbling; Nasdaq down 9% in 3 days
Big tech stocks are continuing their Icarus-like flight path, and more sharp declines for them are dragging Wall Street toward a third straight loss on Tuesday
3:19PM ( 3 hours ago )
California fires bring more chopper rescues, power shutoffs
Helicopters are rescuing more people from the California wildfires as flames chew through bone-dry terrain after a scorching Labor Day weekend
3:13PM ( 3 hours ago )
Trump claims environmental progress, but he's weakened rules
President Donald Trump is out to claim the mantle of environmental steward as he highlights conservation and restoration projects in the critical battleground of Florida
2:32PM ( 4 hours ago )
AP Business - Industries
COVID-19 vaccine latest flashpoint in White House campaign
A vaccine to shield Americans from becoming infected with the coronavirus is emerging as the latest flashpoint in the race for the White House
6:05AM ( 12 hours ago )
The Latest: Trump sees economy rebound by Election Day
President Donald Trump says he’s expecting a strong rebound in the third quarter of 2020, with a good economic report coming out just in time for the November election
2:51PM ( 1 day ago )
The Latest: Spain reports half a million COVID-19 cases
Fueled by a sharp surge of coronavirus contagion just as the school year opens, Spain has now officially more than half a million confirmed coronavirus cases since the beginning of the pandemic
1:29PM ( 1 day ago )
AP Business - Health Care
Trump, Biden charge into volatile final stretch of campaign
For such a volatile year, the White House race between President Donald Trump and Democratic challenger Joe Biden has been remarkably consistent
6:49PM ( 9 minutes ago )
Computer glitches disrupt classes as schools return online
The millions of American youngsters returning to online classes Tuesday are facing technical glitches and other headaches that have plagued remote learning since the onset of the COVID-19 pandemic
6:38PM ( 19 minutes ago )
South Lawn, Rose Garden under repair post-convention
The White House South Lawn and its iconic Rose Garden are undergoing extensive re-sodding and other work after last month’s Republican National Convention turned them into a muddy mess
6:25PM ( 33 minutes ago )
Digital and drive-in, film festivals try to salvage a season
This is normally the time of year when flashy premieres march down red carpets and proclamations of Oscar buzz circle the globe
6:22PM ( 36 minutes ago )
Trump expands ban on new offshore drilling sites in Atlantic
President Donald Trump is seeking to claim the mantle of environmental steward as he announces an expansion of a ban on offshore drilling and highlights conservation projects in Florida
6:21PM ( 37 minutes ago )